BELLEROPHON THERAPEUTICS, INC.At Market Issuance Sales Agreement • May 27th, 2016 • Bellerophon Therapeutics, Inc. • Pharmaceutical preparations • New York
Bellerophon Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with FBR Capital Markets & Co. (“FBR”) and MLV & Co. LLC (“MLV”, each of FBR and MLV individually a “Distribution Agent” and collectively the “Distribution Agents”) as follows:
